What does ovarian cancer chemotherapy drug have?

summary

Ovarian cancer is one of the most common tumors in female reproductive organs. The main site of ovarian cancer is ovary. Ovarian cancer can be divided into benign ovarian cancer and malignant ovarian cancer according to different conditions. Because there are no special symptoms in the early stage of ovarian cancer, it is not easy to find, leading to the spread of cancer cells, the survival rate is relatively low, so the mortality rate of ovarian cancer is still very high. For ovarian cancer can occur at any age, the older the onset, the more. It is more common in menopausal and menopausal women. Let's take a look at the following.

What does ovarian cancer chemotherapy drug have?

First, ovarian cancer is also mainly treated by surgery, assisted by radiotherapy, chemotherapy and traditional Chinese medicine. Systemic chemotherapy is an important adjuvant therapy. Some advanced patients can create favorable conditions for reoperation after chemotherapy.

Second: chemotherapy drugs for ovarian cancer are still limited to these drugs. At present, this field is making great efforts to break through. We hope to combine traditional Chinese medicine and Western medicine to treat ovarian cancer in the future, which can reduce the number of chemotherapy for patients. After all, too many chemotherapy times will also affect people's health.

Third: the commonly used chemotherapy drugs for ovarian cancer include paclitaxel, carboplatin, taxol + poldine, oxaliplatin + poldine, etc. chemotherapy can effectively kill cancer cells and inhibit the proliferation of cancer cells, but normal cells will also be killed, so chemotherapy should not be too frequent.

matters needing attention

Caring for women's health is something that can not be ignored. Cancer is not easy to find symptoms at ordinary times, so usually do more physical examination. If you find any uncomfortable symptoms, you should treat them correctly. If the situation is serious, you should go to the hospital in time to prevent the deterioration of the disease.